Literature DB >> 30580693

Prevalence of Apparent Treatment-Resistant Hypertension.

Daniel W Jones1, Donald Clark1, Marion R Wofford1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30580693      PMCID： PMC6424125          DOI： 10.1161/HYPERTENSIONAHA.118.12271

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  9 in total

1.  Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure.

Authors:  Michael E Ernst; Barry L Carter; Chris J Goerdt; Jennifer J G Steffensmeier; Beth Bryles Phillips; M Bridget Zimmerman; George R Bergus
Journal:  Hypertension       Date:  2006-01-23       Impact factor: 10.190

2.  Systolic Blood Pressure Intervention Trial (SPRINT) and Target Systolic Blood Pressure in Future Hypertension Guidelines.

Authors:  Brent M Egan; Jiexiang Li; C Shaun Wagner
Journal:  Hypertension       Date:  2016-06-27       Impact factor: 10.190

Review 3.  Resistant hypertension and aldosterone: an update.

Authors:  Donald Clark; Mustafa I Ahmed; David A Calhoun
Journal:  Can J Cardiol       Date:  2012-04-21       Impact factor: 5.223

4.  Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.

Authors:  Robert M Carey; David A Calhoun; George L Bakris; Robert D Brook; Stacie L Daugherty; Cheryl R Dennison-Himmelfarb; Brent M Egan; John M Flack; Samuel S Gidding; Eric Judd; Daniel T Lackland; Cheryl L Laffer; Christopher Newton-Cheh; Steven M Smith; Sandra J Taler; Stephen C Textor; Tanya N Turan; William B White
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

Review 5.  Refractory Hypertension: A Novel Phenotype of Antihypertensive Treatment Failure.

Authors:  Tanja Dudenbostel; Mohammed Siddiqui; Suzanne Oparil; David A Calhoun
Journal:  Hypertension       Date:  2016-04-18       Impact factor: 10.190

6.  Efficacy of spironolactone therapy in patients with true resistant hypertension.

Authors:  Fabio de Souza; Elizabeth Muxfeldt; Roberto Fiszman; Gil Salles
Journal:  Hypertension       Date:  2009-10-26       Impact factor: 10.190

7.  Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190

Review 8.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 9.897

9.  Measure Accurately, Act Rapidly, and Partner With Patients (MAP) improves hypertension control in medically underserved patients: Care Coordination Institute and American Medical Association Hypertension Control Project Pilot Study results.

Authors:  Robert B Hanlin; Irfan M Asif; Gregory Wozniak; Susan E Sutherland; Bijal Shah; Jianing Yang; Robert A Davis; Sean T Bryan; Michael Rakotz; Brent M Egan
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-01-05       Impact factor: 3.738
  9 in total
  1 in total

Review 1.  Resistant Hypertension Management: Comparison of the 2017 American and 2018 European High Blood Pressure Guidelines.

Authors:  Guido Grassi; David A Calhoun; Giuseppe Mancia; Robert M Carey
Journal:  Curr Hypertens Rep       Date:  2019-07-18       Impact factor: 5.369
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.